SANA (Sana Biotechnology) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Sana Biotechnology (SANA)

The development of Sana Biotechnology (SANA) relies on scientific research, rendering it independent of economic cycles, with the current indicator standing at 4.71. The linear price action on this chart complements data regarding laboratory modernization and the implementation of automation to expand capacity. The business advantage lies in the creation of modified cells that are not recognized by the immune system, eliminating the risk of rejection during treatment.

Sana Corp (SANA): Rasio Kapitalisasi marang Nilai Buku saka 04.07.2022 nganti 28.10.2026

Rincian metrik keuangan lan pasar Sana Biotechnology Inc (SANA)

- rega lan prakiraan konsensus rega:
Rega saham Sana Biotechnology|SANA - Prakiraan konsensus analis
- data kapitalisasi pasar:
Nilai pasar Sana Bio|SANA - Total Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Sana Biotechnology|SANA - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku sana.com|SANA - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Sana Biotechnology|SANA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sana Bio|SANA - Utang perusahaan|Rasio utang marang kapitalisasi buku Sana Bio|SANA - Utang jangka dawa|Utang jangka cendhak perusahaan Sana Biotechnology
Pambiji fundamental:Sana Biotechnology
Produk merek Sana Bio

This ratio measures the market value premium over net asset value, allowing investors to assess the extent to which the share price is inflated relative to book equity. By analyzing the degree to which market capitalization exceeds book value, one can determine how much the market currently prices in the future success of Sana Biotechnology (SANA) R&D developments in cell modification for cancer and diabetes therapies.

Analisis pesaing

LEGN: Rasio Kapitalisasi Pasar marang Nilai Buku|AUTL (autolus.com) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku ALLO (Allogene)|Koefisien Nilai Pasar marang Nilai Buku RNAC|Rasio Nilai Pasar marang Nilai Buku Cellectis S.A. CLLS|Rasio Kapitalisasi marang Nilai Buku Caribou Biosciences, Inc (CRBU)|Instil Bio, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Genenta Science SpA - Rasio Kapitalisasi marang Aset Bersih|IPSC (Century Therapeutics Inc) - Rasio Nilai Pasar marang Nilai Buku|JSPR: Koefisien Nilai Pasar marang Nilai Buku|sentibio.com (SNTI) - Rasio Nilai Pasar marang Nilai Buku|ADAP (Adaptimmune Therapeutics) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku CERO (CERo Therapeutics Holdings, Inc.)|Koefisien Nilai Pasar marang Nilai Buku Alaunos|ACHL: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas CARGO Therapeutics Inc. CRGX|PSTX: Rasio Kapitalisasi marang Aset Bersih|TSVT - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Gracell Biotechnologies (GRCL)